Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
6,763 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00712140 | Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer | unknown | Phase 3 | 4,000 | Warwick Medical SchoolOTHER | 1 | Sep 2, 2011 | clinicaltrials |
| NCT00302016 | Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 34 | Aug 26, 2011 | clinicaltrials |
| NCT01418430 | Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) | completed | Phase 4 | — | King's College Hospital NHS TrustOTHER | 1 | Aug 22, 2011 | clinicaltrials |
| NCT00655252 | Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 13 | Aug 19, 2011 | clinicaltrials |
| NCT00915811 | Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin(FB-ATG) | terminated | Phase 2 | 20 | King's College Hospital NHS TrustOTHER | 1 | Aug 17, 2011 | clinicaltrials |
| NCT01418118 | Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery(Free4Flow) | completed | Phase 4 | 25 | Oxford University Hospitals NHS TrustOTHER | 1 | Aug 16, 2011 | clinicaltrials |
| NCT01414517 | Study to Prevent Radiation Induced Damage to Bowel Using a Prebiotic Enhanced Diet. | unknown | Phase 3 | 220 | University College London HospitalsOTHER | 1 | Aug 11, 2011 | clinicaltrials |
| NCT00519805 | Dalteparin in Preventing Blood Clots in Patients With Lung Cancer | unknown | Phase 3 | 2,200 | Velindre NHS TrustOTHER_GOV | 1 | Aug 8, 2011 | clinicaltrials |
| NCT00560365 | Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal Cancer | unknown | — | 4,760 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | Aug 8, 2011 | clinicaltrials |
| NCT01097317 | First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 2 | 52 | Wales Cancer Trials UnitOTHER | 1 | Aug 8, 2011 | clinicaltrials |
| NCT00057720 | TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer | completed | Phase 3 | 440 | TelikINDUSTRY | 13 | Jul 25, 2011 | clinicaltrials |
| NCT01087268 | Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer | unknown | Phase 3 | 75 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jul 15, 2011 | clinicaltrials |
| NCT00094653 | MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma | completed | Phase 3 | 1,783 | Bristol-Myers SquibbINDUSTRY | 13 | Jul 11, 2011 | clinicaltrials |
| NCT00748891 | DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study) | completed | Phase 1 | 35 | AstraZenecaINDUSTRY | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00485979 | Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients(SATIN) | completed | Phase 2 | 330 | SanofiINDUSTRY | 8 | Jun 28, 2011 | clinicaltrials |
| NCT00523419 | Chemotherapy for Patients With Osteosarcoma | completed | Phase 2 | 32 | Eli Lilly and CompanyINDUSTRY | 5 | Jun 28, 2011 | clinicaltrials |
| NCT00550004 | Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine(RP101) | terminated | Phase 2 | 153 | SciClone PharmaceuticalsINDUSTRY | 13 | Jun 8, 2011 | clinicaltrials |
| NCT00076986 | The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme | completed | Phase 3 | 300 | INSYS Therapeutics IncINDUSTRY | 6 | Jun 6, 2011 | clinicaltrials |
| NCT00322517 | Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer | completed | Phase 2 | 90 | PfizerINDUSTRY | 5 | May 17, 2011 | clinicaltrials |
| NCT00616135 | Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy(RESTORE-2) | completed | Phase 4 | 71 | Cytori TherapeuticsINDUSTRY | 4 | May 17, 2011 | clinicaltrials |
| NCT01316744 | Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain | unknown | Phase 3 | 214 | University of GlasgowOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT01324076 | Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery | unknown | Phase 3 | 412 | University College, LondonOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT00099606 | Phase I (PH I) Mad Refractory Solid Tumor Study | completed | Phase 1 | 60 | Bristol-Myers SquibbINDUSTRY | 2 | Apr 19, 2011 | clinicaltrials |
| NCT01335555 | The Effect of Chemotherapy on Lactate Threshold in Cancer Patients | completed | — | 89 | Liverpool University Hospitals NHS Foundation TrustOTHER_GOV | 1 | Apr 19, 2011 | clinicaltrials |
| NCT00006479 | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | unknown | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Apr 18, 2011 | clinicaltrials |
| NCT00101647 | Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia | completed | Phase 2 | 197 | Bristol-Myers SquibbINDUSTRY | 23 | Apr 15, 2011 | clinicaltrials |
| NCT00101595 | Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | completed | Phase 2 | 96 | Bristol-Myers SquibbINDUSTRY | 20 | Apr 14, 2011 | clinicaltrials |
| NCT00179621 | Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality | completed | Phase 3 | 205 | Celgene CorporationINDUSTRY | 9 | Apr 14, 2011 | clinicaltrials |
| NCT01196403 | Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer | unknown | Phase 2 | 92 | Wales Cancer Trials UnitOTHER | 1 | Apr 1, 2011 | clinicaltrials |
| NCT00081029 | Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia | unknown | Phase 3 | 84 | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 23, 2011 | clinicaltrials |
| NCT00372567 | Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors | terminated | Phase 3 | 69 | PfizerINDUSTRY | 7 | Mar 17, 2011 | clinicaltrials |
| NCT00417079 | XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer(TROPIC) | completed | Phase 3 | 755 | SanofiINDUSTRY | 26 | Mar 10, 2011 | clinicaltrials |
| NCT00496067 | Uterine Artery Occlusion for Fibroid Related Bleeding | terminated | N/A | 91 | Ethicon, Inc.INDUSTRY | 7 | Mar 9, 2011 | clinicaltrials |
| NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer(TAX316) | completed | Phase 3 | 1,491 | SanofiINDUSTRY | 20 | Feb 16, 2011 | clinicaltrials |
| NCT01076751 | Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients(PORTREAT) | terminated | — | 82 | SanofiINDUSTRY | 5 | Feb 14, 2011 | clinicaltrials |
| NCT00285103 | SPC2996 in Chronic Lymphocytic Leukaemia | completed | Phase 1 / Phase 2 | 46 | Santaris Pharma A/SINDUSTRY | 4 | Feb 2, 2011 | clinicaltrials |
| NCT00206219 | Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX) | completed | Phase 3 | 477 | AstraZenecaINDUSTRY | 25 | Jan 27, 2011 | clinicaltrials |
| NCT00082277 | Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer(SABRE) | completed | Phase 4 | 237 | AstraZenecaINDUSTRY | 8 | Jan 26, 2011 | clinicaltrials |
| NCT00255489 | A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer | completed | Phase 1 | 36 | AstraZenecaINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00661609 | A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer | completed | Phase 2 | 54 | AstraZenecaINDUSTRY | 5 | Jan 12, 2011 | clinicaltrials |
| NCT00354562 | A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 75 | AbbottINDUSTRY | 4 | Jan 7, 2011 | clinicaltrials |
| NCT00818051 | Radiation Therapy in Treating Women Who Have Undergone Breast Conservation Surgery and Systemic Therapy for Early Breast Cancer | unknown | Phase 3 | 840 | Institute of Cancer Research, United KingdomOTHER | 1 | Jan 7, 2011 | clinicaltrials |
| NCT01270906 | Safety of CHIR-258 (TKI258) in Advanced Solid Tumors | terminated | Phase 1 | 35 | Novartis PharmaceuticalsINDUSTRY | 1 | Jan 5, 2011 | clinicaltrials |
| NCT00268892 | Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer | completed | Phase 2 / Phase 3 | 278 | Ferring PharmaceuticalsINDUSTRY | 10 | Dec 24, 2010 | clinicaltrials |
| NCT00432640 | Assessment of Surgical sTaging vs Endoscopic Ultrasound in Lung Cancer: a Randomized Clinical Trial (ASTER Study) | completed | N/A | 240 | University Hospital, GhentOTHER | 3 | Dec 16, 2010 | clinicaltrials |
| NCT00116753 | A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer | completed | Phase 2 | 460 | Ferring PharmaceuticalsINDUSTRY | 11 | Dec 10, 2010 | clinicaltrials |
| NCT00673205 | (Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer(Capri) | completed | Phase 3 | 3,588 | AstraZenecaINDUSTRY | 16 | Dec 10, 2010 | clinicaltrials |
| NCT00516438 | Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan | completed | Phase 1 | 48 | AstraZenecaINDUSTRY | 1 | Dec 8, 2010 | clinicaltrials |
| NCT01250015 | Does Numerical And Pictorial Information On Risk And Benefit Affects The Uptake Of Colorectal Cancer Screening? | completed | — | 400 | County Durham and Darlington NHS Foundation TrustOTHER_GOV | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00746031 | Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids | completed | Phase 4 | 30 | University of EdinburghOTHER | 1 | Oct 25, 2010 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials